Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report) saw a significant growth in short interest in August. As of August 31st, there was short interest totaling 130,094 shares, a growth of 1,517.7% from the August 15th total of 8,042 shares. Approximately 23.7% of the company’s stock are short sold. Based on an average daily volume of 6,364,686 shares, the days-to-cover ratio is currently 0.0 days.
Analyst Upgrades and Downgrades
Several analysts have commented on the stock. Wall Street Zen raised shares of Tenon Medical to a “hold” rating in a research report on Saturday, August 29th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Tenon Medical in a research note on Friday, July 17th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Tenon Medical presently has an average rating of “Hold”.
View Our Latest Stock Analysis on TNON
More Tenon Medical News
- Positive Sentiment: Warrant exercise raises approximately $2.87 million. An institutional investor agreed to immediately exercise warrants covering 572,179 shares, providing Tenon with gross cash proceeds of approximately $2.872 million. The additional liquidity may help support operations and commercialization of its medical-device business. Tenon Medical Announces Warrant Inducement
- Positive Sentiment: Convertible debt repayment removes a financing overhang. Tenon completed repayment of convertible debt, a development that can reduce obligations and potential future conversion-related dilution. The announcement contributed to strong premarket interest in the stock. Tenon Medical Completes Repayment of Convertible Debt
- Neutral Sentiment: Trading was repeatedly paused for LULD volatility halts. Multiple temporary halts indicate unusually sharp price movements and elevated speculative trading, rather than a fundamental change in the company’s outlook.
- Neutral Sentiment: Short-interest data is inconsistent. One report listed 130,094 shares sold short as of August 31, while a subsequent update showed zero shares as of September 10. The conflicting figures make it difficult to assess whether short covering materially contributed to the move.
- Negative Sentiment: New warrants could substantially dilute shareholders. In exchange for exercising the existing warrants, investors will receive new warrants for up to 858,269 shares—150% of the shares issued—with a $5.02 exercise price. These securities could increase the future share count if exercised. WallachBeth Capital Announces Tenon Medical Warrant Inducement
- Negative Sentiment: A major shareholder reported heavy selling. HRT Financial LP sold more than 125,000 shares across September 9-10, substantially reducing its reported position, although it also disclosed purchases during the period. The large sales may weigh on investor confidence and suggest near-term profit-taking or reduced conviction.
Insider Activity
In other news, major shareholder Financial Lp Hrt acquired 67,925 shares of the business’s stock in a transaction on Thursday, September 10th. The shares were purchased at an average cost of $3.63 per share, with a total value of $246,567.75. Following the acquisition, the insider directly owned 15,839 shares of the company’s stock, valued at $57,495.57. The trade was a -130.41% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last 90 days, insiders purchased 129,945 shares of company stock worth $500,468 and sold 136,599 shares worth $605,467. 17.71% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in TNON. Jane Street Group LLC purchased a new stake in shares of Tenon Medical in the 1st quarter worth about $29,000. Geode Capital Management LLC boosted its stake in Tenon Medical by 34.6% during the fourth quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock worth $63,000 after acquiring an additional 17,137 shares in the last quarter. Finally, DRW Securities LLC purchased a new stake in Tenon Medical in the fourth quarter worth about $98,000. Hedge funds and other institutional investors own 22.74% of the company’s stock.
Tenon Medical Stock Performance
Shares of TNON opened at $5.93 on Friday. The firm has a market cap of $3.96 million, a price-to-earnings ratio of -0.13 and a beta of 1.36. Tenon Medical has a fifty-two week low of $2.40 and a fifty-two week high of $50.40. The firm has a 50 day moving average price of $6.21 and a 200-day moving average price of $18.13.
Tenon Medical (NASDAQ:TNON – Get Free Report) last released its earnings results on Thursday, August 13th. The company reported ($12.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($8.40) by ($3.95). The company had revenue of $1.28 million during the quarter, compared to the consensus estimate of $1.54 million. Tenon Medical had a negative net margin of 257.85% and a negative return on equity of 907.60%.
Tenon Medical Company Profile
Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.
Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.
Featured Articles
- Five stocks we like better than Tenon Medical
- American Eagle Goes on Sale: Is It Time to Buy?
- MarketBeat Week in Review – 09/07 – 09/11
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
